These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 18701572

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
    Brola W, Sobolewski P, Szczuchniak W, Góral A, Fudala M, Przybylski W, Opara J.
    Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.
    van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ.
    J Neurol; 2007 May; 254(5):581-90. PubMed ID: 17426912
    [Abstract] [Full Text] [Related]

  • 5. Decreased serum vitamin D levels in Japanese patients with multiple sclerosis.
    Niino M, Sato S, Fukazawa T, Masaki K, Miyazaki Y, Matsuse D, Yamasaki R, Takahashi E, Kikuchi S, Kira J.
    J Neuroimmunol; 2015 Feb 15; 279():40-5. PubMed ID: 25669999
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D as a protective factor in multiple sclerosis.
    Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P.
    Neurology; 2012 Nov 20; 79(21):2140-5. PubMed ID: 23170011
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.
    Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, Bergsland N, Hussein S, Cherneva M, Willis L, Heininen-Brown M, Ramanathan M.
    J Neurol Neurosurg Psychiatry; 2011 Feb 20; 82(2):189-95. PubMed ID: 21047880
    [Abstract] [Full Text] [Related]

  • 10. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis.
    Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, Chao MJ, Vieth R, Sadovnick AD, Ebers GC.
    Am J Clin Nutr; 2008 Aug 20; 88(2):441-7. PubMed ID: 18689381
    [Abstract] [Full Text] [Related]

  • 11. Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
    Behrens JR, Rasche L, Gieß RM, Pfuhl C, Wakonig K, Freitag E, Deuschle K, Bellmann-Strobl J, Paul F, Ruprecht K, Dörr J.
    Eur J Neurol; 2016 Jan 20; 23(1):62-7. PubMed ID: 26220765
    [Abstract] [Full Text] [Related]

  • 12. 25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: A cross-sectional study.
    Karampoor S, Zahednasab H, Ramagopalan S, Mehrpour M, Safarnejad Tameshkel F, Keyvani H.
    J Neuroimmunol; 2016 Jan 15; 290():47-8. PubMed ID: 26711568
    [Abstract] [Full Text] [Related]

  • 13. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.
    J Neurol Neurosurg Psychiatry; 2008 Feb 15; 79(2):152-7. PubMed ID: 17578859
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.
    Munger KL, Hongell K, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A.
    Neurology; 2017 Oct 10; 89(15):1578-1583. PubMed ID: 28904091
    [Abstract] [Full Text] [Related]

  • 17. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
    Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A.
    Mult Scler; 2005 Jun 10; 11(3):266-71. PubMed ID: 15957505
    [Abstract] [Full Text] [Related]

  • 18. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
    Fitzgerald KC, Munger KL, Köchert K, Arnason BG, Comi G, Cook S, Goodin DS, Filippi M, Hartung HP, Jeffery DR, O'Connor P, Suarez G, Sandbrink R, Kappos L, Pohl C, Ascherio A.
    JAMA Neurol; 2015 Dec 10; 72(12):1458-65. PubMed ID: 26458124
    [Abstract] [Full Text] [Related]

  • 19. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis.
    Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R.
    Ann N Y Acad Sci; 2009 Sep 10; 1173():515-20. PubMed ID: 19758194
    [Abstract] [Full Text] [Related]

  • 20. 25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis.
    Slavov GS, Manova MG, Trenova AG, Kostadinova II, Pavlov PI, Mateva NG, Zahariev ZI.
    Folia Med (Plovdiv); 2015 Sep 10; 57(3-4):200-6. PubMed ID: 27180346
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.